BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
COF
Capital One Financial Corporation
COF has the edge over BAC overall, supported by stronger fundamentals and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
COF Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
COF's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like COF.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over COF in the historical PE scenario, which offers more potential upside but is not a forecast.
COF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.4x | $96.85 | -50% |
| Forward | 8.4x | $194 | — |
| Fair | 11x | $195 | +0.7% |
| Current | 11x | $194 | — |
| Expensive | 45x | $817 | +322% |
Historical ranges are pointers, not guarantees.
COF's PE is in its fair range at 11x. If earnings grow as analysts expect, today's price would be 8.4x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
COF Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for COF, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over COF on earnings, with more consistent year-over-year improvement.
COF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.94 | +27% |
| Q3 2026 | $18.01 | +660% |
| Q2 2026 | $17.23 | +784% |
| Q1 2026 | $3.92 | -67% |
| Q4 2025 | $4.03 | -65% |
| Q3 2025 | $2.37 | -78% |
| Q2 2025 | $1.95 | -82% |
| Q1 2025 | $11.91 | -6.7% |
| Q4 2024 | $11.59 | -3% |
COF's earnings per share have fallen from their peak: $18.01 over the past year, against $26.94 in late 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over COF on profitability, with a higher operating margin.
COF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.3B | +6.4% |
| Q2 2026 | $15.9B | +27% |
| Q1 2026 | $15.2B | +52% |
| Q4 2025 | $15.6B | +53% |
| Q3 2025 | $15.4B | +53% |
| Q2 2025 | $12.5B | +31% |
| Q1 2025 | $10B | +6.4% |
| Q4 2024 | $10.2B | +7.2% |
COF has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | -0.6 points |
| Q2 2026 | 24% | +72 points |
| Q1 2026 | 18% | +0.4 points |
| Q4 2025 | 13% | -0.8 points |
| Q3 2025 | 29% | +6.4 points |
| Q2 2025 | -47% | -54 points |
| Q1 2025 | 17% | +0.5 points |
| Q4 2024 | 14% | +4.5 points |
COF's operating margin was 28% last quarter, down 0.6 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
COF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.3B | -39% |
| Q2 2026 | $8.1B | +43% |
| Q1 2026 | $5.5B | +27% |
| Q4 2025 | $7.4B | +253% |
| Q3 2025 | $8.8B | +43% |
| Q2 2025 | $5.7B | -4.8% |
| Q1 2025 | $4.3B | +56% |
| Q4 2024 | $2.1B | -69% |
COF has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over COF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
COF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -11.6M shares |
| 1 year | -4.7% | -30M shares |
| 3 years | +59% | +226M shares |
| 5 years | +38% | +169M shares |
| Available history | +30% | +140M shares |
COF has 610M diluted shares, down 4.7% from a year ago, with $10.7B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.7B |
| Q2 2026 | $2.7B |
| Q1 2026 | $2.8B |
| Q4 2025 | $2.5B |
| Q3 2025 | $1B |
| Q2 2025 | $167M |
| Q1 2025 | $375M |
| Q4 2024 | $161M |
COF spent $10.7B buying back its own shares over the past year, about six times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
COF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 5.1x | High |
| Q4 2025 | 6.4x | High |
| Q3 2025 | 7.7x | High |
| Q2 2025 | 16.4x | High |
| Q1 2025 | 4.1x | High |
| Q4 2024 | 4.7x | High |
COF has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
COF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 26.9 | Neutral |
COF's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
COF PE vs Financial Services Sector
| Metric | COF | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 49 | 63 | 14 pts below |
COF has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
COF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $199.7 | 3.1% below |
| 20 week MA | $206.7 | 6.3% below |
| 50 week MA | $206.3 | 6.2% below |
| 100 week MA | $203.1 | 4.7% below |
| 200 week MA | $164.7 | 18% above |
COF has fallen below most of its moving averages, though it's still 18% above its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over COF on returns for 2026, with the stronger performance.
COF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $103.0 | $97.3 | -5.5% |
| 2021 | $97.3 | $145.1 | +49% |
| 2022 | $145.1 | $90.7 | -37% |
| 2023 | $90.7 | $131.1 | +45% |
| 2024 | $131.1 | $180.2 | +37% |
| 2025 | $180.2 | $249.3 | +38% |
| 2026 YTD | $249.3 | $193.6 | -22% |
COF has finished higher in four of the last six years. It's down 22% so far in 2026.